New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Top of the News-dtet
Generalizing Genomics Learning
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
Lost Ground: Cancer Screening in the COVID-19 Era
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Microbiology Testing Rates Low For Hospital-Acquired Infections
From - Diagnostic Testing & Emerging Technologies
The European Centre for Disease Control and Prevention (ECDC) estimates that there are 9 million cases of health care-associated infections…
Compliance Alert: FDA Warning Letter to Inova Genomics Laboratory
New Federal Taskforce to Speed Implementation of Emergency Use Diagnostics
From - Diagnostic Testing & Emerging Technologies
Three federal agencies announced the creation of a new taskforce to provide timely recommendations to laboratories for rapid implementation of…
Genetic Risk of Prostate Cancer Underestimated; Testing Guidelines Miss Men With Elevated Prostate Cancer Risk
...
Already a member? Log in here
New Studies Question Utility of Gene Expression Testing for Cancers With Unknown Primary Site, Low-Risk Breast Cancer
From - Diagnostic Testing & Emerging Technologies
Gene expression profiling has been making inroads into clinical cancer care, with application in cancer classification, most notably with…
Diagnostics Sector Saw Increased Investment, Exits in 2018
From - Diagnostic Testing & Emerging Technologies
Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment…
Newborn Sequencing Delivers Some Unanticipated Findings
...
Already a member? Log in here
New Broad All-Payor Kickback Law Impacting Laboratories, Commission-based Compensation and more
Most Oncologists Report Using Sequencing-Based Panels In Practice
From - Diagnostic Testing & Emerging Technologies
The majority of U.S. oncologists report using next-generation sequencing-based (NGS-based) tests to guide patient care, according to a study published…
Big Data Can Reshape Lab Reference Values in the Era of Personalized Medicine
From - Diagnostic Testing & Emerging Technologies
As might be expected, there are substantial differences in "normal" laboratory values determined by healthy outpatients and critically ill patients in…